The TriPorTech GmbH was founded in June 2005 by Dr. Christian Schell in Lübeck, Germany. A goal of the TriPorTech GmbH is the production, research and marketing of porphyrins and porphyrin-like chemicals. The main emphasis is placed on industrial and pharmaceutical applications of these compounds. In addition, researchers will be delighted by an extensive product spectrum. Due to new manufacturing technologies, the TriPorTech GmbH is able to synthesize porphyrins in industrially useful quantities with an exceptionally high quality and an interesting price-performance relationship.

The TriPorTech GmbH is one of the few Life Science enterprises in Germany, which are promoted by pre seed capital. This is capital of the technology holding company tbg, a daughter of the Kfw bankers' syndicate. In financial-strategic questions the enterprise is accompanied by the representative of CatCap GmbH Hamburg, Mark Miller. In the field of photobiology and in marketing questions the member of the advisory board Dr. rer. nat. H. Diddens advice the TriPorTech GmbH.